Last $1.00 USD
Change Today +0.02 / 2.04%
Volume 9.5K
DYAI On Other Exchanges
As of 5:20 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

dyadic international inc (DYAI) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/18/14 - $1.87
52 Week Low
12/11/14 - $0.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

dyadic international inc (DYAI) Related Bloomberg News

View More Bloomberg News

dyadic international inc (DYAI) Related Businessweek News

No Related Businessweek News Found

dyadic international inc (DYAI) Details

Dyadic International, Inc., a biotechnology company, discovers, develops, manufactures, and sells enzymes, proteins, peptides, and other bio-molecules for the bioenergy, biochemical, industrial enzyme, and biopharmaceutical industries. It primarily manufactures and sells liquid and dry enzyme products for use in the animal feed, pulp and paper, starch and alcohol, food and brewing, textiles, and bio fuels industries. The company utilizes an integrated technology platform based on its patented and proprietary C1 fungus technology, which enables the development and manufacture of various proteins and enzymes, as well as other biological products, such as antibodies, vaccines, proteins, and polypeptides for the biopharmaceutical industry. It also develops fungal strains that produce enzymes used in animal health and nutrition applications. The company has operations in the United States and the Netherlands. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

39 Employees
Last Reported Date: 10/9/14
Founded in 1979

dyadic international inc (DYAI) Top Compensated Officers

Chief Executive Officer, President, Founder, ...
Total Annual Compensation: $385.4K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $195.4K
Vice President of Operations
Total Annual Compensation: $225.0K
Compensation as of Fiscal Year 2013.

dyadic international inc (DYAI) Key Developments

Dyadic International Appoints Michael Tarnok as Chairman of the Board of Directors

Dyadic International, Inc. announced the appointment of Michael Tarnok as the company's Chairman of the Board of Directors. Mr. Tarnok will continue to serve on the company's audit and compensation committees. Mr. Tarnok has extensive experience in the pharmaceutical industry across many key areas including finance, operations and marketing. He is also the current Chairman and former Interim CEO of Keryx Biopharmaceuticals, Inc.

Dyadic International, Inc. Extends Debt Maturity Date on Note Payable

Dyadic International, Inc. announced that it has entered into an agreement to extend the maturity date of the $1.4 million non-convertible 9.5% note payable to January 1, 2016. All other terms and conditions of the debt remain unchanged. The company has entered into agreements with all of its outstanding promissory note holders to extend their maturity dates to January 1, 2016.

Dyadic International, Inc. Presents at Pacific Rim Summit 2014, Dec-08-2014 02:30 PM

Dyadic International, Inc. Presents at Pacific Rim Summit 2014, Dec-08-2014 02:30 PM. Venue: San Diego, California, United States. Speakers: Danai Eric Brooks, Chief Operating Officer and Executive Vice President.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DYAI:US $1.00 USD +0.02

DYAI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Koninklijke DSM NV €50.46 EUR +1.19
Lonza Group AG SFr.123.90 CHF +6.30
Merck KGaA €97.78 EUR +1.36
Novozymes A/S kr317.00 DKK -0.30
Teva Pharmaceutical Industries Ltd $56.51 USD -0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation DYAI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYADIC INTERNATIONAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at